Home > Healthcare > Medical Devices > Therapeutic Devices > ENT Devices Market

ENT Devices Market Share

Report ID: GMI496
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

ENT Devices Market Share

The ENT devices industry is characterized by the presence of several established and emerging players that offer a variety of treatments across the globe. The market players compete based on factors such as treatment quality, innovation, regulatory compliance, customer service, and pricing strategies.

ENT Devices Market Companies

Prominent players operating in the industry include:

Atos Medical
Boston Scientific Corporation
Cochlear
DeSoutter Medical
Johnson & Johnson
Lumenis
Medtronic
Meril Life Sciences
Narang Medical
Nouvag
Olympus Corporation
Smith & Nephew
Sonova Group
Stryker Corporation
Vega Medical
Welch Allyn
WestCMR
Zimmer Biomet

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size for ENT devices was valued at USD 20.8 billion in 2023 and is expected to reach USD 36 billion by 2032, driven by a CAGR of 6.3% from 2024 to 2032.

Hearing aids accounted for a 37.2% market share in 2023, due to the increasing prevalence of hearing impairments and advancements in hearing aid technology.

North America market was valued at USD 8.1 billion in 2023, driven by a high prevalence of ENT disorders, advanced healthcare infrastructure, and strong technological innovation.

Major players in the industry include Atos Medical, Boston Scientific Corporation, Cochlear, DeSoutter Medical, Johnson & Johnson, Lumenis, Medtronic, Meril Life Sciences, Narang Medical, Nouvag, and Olympus Corporation.